415 related articles for article (PubMed ID: 25248595)
1. Medical approach to pituitary tumors.
Neggers SJ; van der Lely AJ
Handb Clin Neurol; 2014; 124():303-16. PubMed ID: 25248595
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
3. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives.
Cuny T; Barlier A; Feelders R; Weryha G; Hofland LJ; Ferone D; Gatto F
Ann Endocrinol (Paris); 2015 Feb; 76(1):43-58. PubMed ID: 25556152
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
5. Future treatment strategies of aggressive pituitary tumors.
Lamberts SW; Hofland LJ
Pituitary; 2009; 12(3):261-4. PubMed ID: 19003539
[TBL] [Abstract][Full Text] [Related]
6. The Role of Dopamine Agonists in Pituitary Adenomas.
Giraldi EA; Ioachimescu AG
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):453-474. PubMed ID: 32741482
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pituitary tumors: somatostatin.
Tichomirowa MA; Daly AF; Beckers A
Endocrine; 2005 Oct; 28(1):93-100. PubMed ID: 16311415
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment of pituitary adenomas.
Oyesiku NM
Clin Neurosurg; 2005; 52():234-42. PubMed ID: 16626076
[No Abstract] [Full Text] [Related]
9. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
10. Pituitary-directed medical therapy in Cushing's disease.
Petersenn S; Fleseriu M
Pituitary; 2015 Apr; 18(2):238-44. PubMed ID: 25627118
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Pituitary Adenomas: A Review.
Molitch ME
JAMA; 2017 Feb; 317(5):516-524. PubMed ID: 28170483
[TBL] [Abstract][Full Text] [Related]
12. Cabergoline use for pituitary tumors and valvular disorders.
Auriemma RS; Pivonello R; Ferreri L; Priscitelli P; Colao A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):89-97. PubMed ID: 25732645
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.
Minniti G; Esposito V; Piccirilli M; Fratticci A; Santoro A; Jaffrain-Rea ML
Eur J Endocrinol; 2005 Dec; 153(6):723-35. PubMed ID: 16322376
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of Cushing's disease: somatostatin analogues and pasireotide.
Pedroncelli AM
Neuroendocrinology; 2010; 92 Suppl 1():120-4. PubMed ID: 20829632
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.
Cannavo S; Messina E; Albani A; Ferrau F; Barresi V; Priola S; Esposito F; Angileri F
Endocrine; 2016 Jun; 52(3):481-7. PubMed ID: 25877016
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours.
Colao A; Filippella M; Pivonello R; Di Somma C; Faggiano A; Lombardi G
Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S57-S63. PubMed ID: 17413190
[TBL] [Abstract][Full Text] [Related]
18. Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.
Biller BM; Colao A; Petersenn S; Bonert VS; Boscaro M
BMC Endocr Disord; 2010 May; 10():10. PubMed ID: 20478050
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes.
Steele CA; MacFarlane IA; Blair J; Cuthbertson DJ; Didi M; Mallucci C; Javadpour M; Daousi C
Eur J Endocrinol; 2010 Oct; 163(4):515-22. PubMed ID: 20685833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]